A phase I study of imexon inj plus gemcitabine as first-line therapy for advanced pancreatic cancer with preclinical mechanistic study of dose limiting toxicity

被引：1
|
作者：
Cohen, S. J.
Zalupski, M. M.
Modiano, M. R.
Conkling, P. R.
Patt, Y. Z.
Davis, P.
Dorr, R. T.
Boytim, M. L.
Hersh, E. M.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Arizona Oncol Associates, Tucson, AZ USA
[4] Virgina Oncol Associates, Norfolk, VA USA
[5] Univ New Mexico, Albuquerque, NM 87131 USA
[6] Univ Arizona, Tucson, AZ USA
[7] Amplimed Corp, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4619
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer
    Choi, Brian
    Robins, H. Ian
    Schiller, Joan
    Mehta, Minesh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 175 - 179
  • [22] A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer
    Brian Choi
    H. Ian Robins
    Joan Schiller
    Minesh Mehta
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 175 - 179
  • [23] Phase II randomized study of gemcitabine plus vinorelbine versus gemcitabine plus mitoxantrone in advanced metastatic breast cancer elderly women: A first-line chemotherapy
    Latorre, A.
    Monticelli, G.
    Giotta, F.
    Calabrese, R.
    Lorusso, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII145 - VII146
  • [24] Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study
    Guo, Jhe-Cyuan
    Yang, Shih-Hung
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 634 - 642
  • [25] Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study
    Jhe-Cyuan Guo
    Shih-Hung Yang
    International Journal of Clinical Oncology, 2014, 19 : 634 - 642
  • [26] Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer
    Possinger, K
    Kaufmann, M
    Coleman, R
    Stuart, NSA
    Helsing, M
    Ohnmacht, U
    Arning, M
    ANTI-CANCER DRUGS, 1999, 10 (02) : 155 - 162
  • [27] A phase II study of biweekly gemcitabine at fixed dose rate infusion plus S1 as first-line chemotherapy in patients with locally advanced or metastatic pancreatic cancer.
    Xiang, Xj
    Zhang, L.
    Li, Jh
    Zhan, Zy
    Feng, M.
    Chen, J.
    Xiong, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [28] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    F Cappuzzo
    S Novello
    F De Marinis
    V Franciosi
    M Maur
    A Ceribelli
    V Lorusso
    F Barbieri
    L Castaldini
    E Crucitta
    L Marini
    S Bartolini
    G V Scagliotti
    L Crinò
    British Journal of Cancer, 2005, 93 : 29 - 34
  • [29] Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Cappuzzo, F
    Novello, S
    De Marinis, F
    Franciosi, V
    Maur, M
    Ceribelli, A
    Lorusso, V
    Barbieri, F
    Castaldini, L
    Crucitta, E
    Marini, L
    Bartolini, S
    Scagliotti, GV
    Crinò, L
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 29 - 34
  • [30] Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer
    Kozloff, M.
    Chuang, E.
    Roy, J.
    Starr, A.
    Gowland, P. A.
    Tarpey, M. J.
    Collier, M.
    Verkh, L.
    Kern, K.
    Miller, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 216 - 216
12345